A STUDY ON PREVALENCE AND MAINTENANCE OF HYPERTENSION ON CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING MAINATENANCE HEMODIALYSIS
DOI:
https://doi.org/10.53555/zsav1r03Keywords:
Chronic kidney disease, hemodialysis, hypertension, blood pressure control, sodium restriction, polypharmacyAbstract
Background: hypertension is a majority comorbidity in chronic kidney disease (CKD) patients undergoing maintenance hemodialysis (MHD), ye it is prevalence, control rates, and optimal management strategies in clinical practices remain inadequately characterized
Objectives: the study aimed to determine the prevalence of hypertension, evaluated blood pressure control rates , identify associated factors, and assess the effectiveness of management strategies in CKD patients receiving MHD
Methods: In this observational study, 50 CKD patients undergoing MHD were evaluated. Data on demographic characteristics, blood pressure measurements, antihypertensives medications, dietary adherence, and complications were collected through medical record review. Hypertension control was defined as <140/90 mmHg according to JNC 7 guidelines.
Results: the prevalence of hypertension was 94% (47/50) with only 25% (12/47) achieving blood pressure control. A significant association was found between uncontrolled hypertension and diabetes mellitus (p=0.03), with 87.2% of patients requiring antihypertensives medications, notably patients adhering to strict sodium restrictions (<2g/day) demonstrated significantly higher control rates (63.2%) compared to non-adherent patients (0%).
Conclusion: hypertension is highly prevalent but poorly controlled in CKD patients on MHD. These overall findings emphasize the need for a paradigm shift toward non-pharmacological interventions as foundational therapy to improve hypertension control and reduce complications in this high-risk population
References
1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298:2038–47.
2. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015; 88:950–7.
3. Martin W F, Armstrong L E, Rodriguez N R. Dietary protein intake and Renal function. Nutrition and Metabolism, 2(1):25, 2005.
4. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012; 380:1662–1673.
5. Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy [e-pub ahead of print]. Lancet. http://dx.doi.org/10.1016/S0140-6736(17) 30788-2. Accessed May 1, 2017.
6. Fujii H, Joki N. Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol. 2017;21(supply 1):53–63.
7. Levin NW.Intradialytic Hypertension: 1. Semin dial. 1993; 6:371.
8. Chobanian A V, Bakri’s G L, Black H R, Cushman W C, Green L A, Izzo Jr J L, Jones D W, Materson B J, Oparil S, Wright Jr J T, Roccella E J. The seventh report of the joint national committee on prevention, detection, evaluation and treatment 7 2017ppp 20925 © Inventi Journals (P) Ltd Published on Web 29/11/2016, www.inventi.in RESEARCH ARTICLE of high blood pressure: the JNC 7 report. JAMA, 289(19):2560 71, 2003.
9. Elaine Ku, Benjamin J. Lee, Jenny Wei, Matthew R. Weir, Hypertension in CKD: Core Curriculum 2019, American Journal of Kidney Diseases, Volume 74, Issue 1,2019,
10. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet.2013;382:339–52
11. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334:13–18. Doi: 10.1056/NEJM199601043340103
12.Lee H, Kwon SH, Jeon JS, Noh H, Han DC, Kim H. Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients. Kidney Res Clin Pract. 2022; 41:31–42. Doi: 10.23876/j.krcp.21.099
13. Sim JJ, Shi J, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014; 64:588–597. Doi: 10.1016/j.jacc.2014.04.065
14. Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019; 79:365–379. doi: 10.1007/s40265-019-1064-1
15. CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005; 165:923–928. doi: 10.1001/archinte.165.8.923
16. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003; 41:1341–1345. doi: 10.1161/01.HYP.0000069699.92349.8C.
17.Garofalo C, Borrelli S, Pacilio M, Minutolo R, Chiodini P, De Nicola L, Conte G. Hypertension and prehypertension and prediction of development of decreased estimated GFR in the general population: a meta-analysis of cohort studies. Am J Kidney Dis. 2016; 67:89–97. doi: 10.1053/j.ajkd.2015.08.027
18.Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberbauer R, Klauser-Braun R. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008; 23:1265–1273. doi: 10.1093/ndt/gfm790
19. Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular End stage Disease) study. Am J Kidney Dis. 2012; 60:804–811. doi: 10.1053/j.ajkd.2012.06.017
20. Amit Ranjan, Akhil Kolli, M Raghu Bapi Raju et al, Management of hypertension in CKD Patients Undergoing Maintenance Hemodialysis; A prospective cross Sectional. Inventi Rapid: Pharmacy Practice, 2027(1):1-8, 2016
21.Tedla, F. M., Brar, A., Browne, R., Brown, C., Hypertension in Chronic Kidney Disease: Navigating the Evidence, International Journal of Hypertension, 2011, 132405, 9 pages, 2011. https://doi.org/10.4061/2011/132405
